{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:57:19Z","timestamp":1792403839705,"version":"4.4.0"},"reference-count":46,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"1","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2020,1,29]]},"DOI":"10.1167\/iovs.61.1.3","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T11:30:54Z","timestamp":1580297454000},"page":"3","source":"Crossref","is-referenced-by-count":13,"title":["HIF1\u03b1-mediated TRAIL Expression Regulates Lacrimal Gland Inflammation in Dry Eye Disease"],"prefix":"10.1167","volume":"61","author":[{"given":"Yong Woo","family":"Ji","sequence":"first","affiliation":[{"name":"Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Department of Ophthalmology, National Health Insurance Service Ilsan Hospital, Goyang, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon H.","family":"Lee","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Biology, Myung-gok Eye Research Institute, Konyang University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Choi","sequence":"additional","affiliation":[{"name":"Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Goo","family":"Kang","sequence":"additional","affiliation":[{"name":"Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Yul","family":"Seo","sequence":"additional","affiliation":[{"name":"Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Suk","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Guro Hospital, Korea University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Chang","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Cardiovascular and Metabolic Diseases Etiology Research Center, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Keun","family":"Lee","sequence":"additional","affiliation":[{"name":"Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea"},{"name":"Institute of Vascular Disease and Metabolism, Yonsei University College of Medicine, Seoul, Korea"},{"name":"College of Pharmacy, Yonsei University, Incheon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"key":"bib2","first-page":"90","article-title":"Dry eye disease: an immune-mediated ocular surface disorder","volume":"130","author":"Stevenson","year":"2012","journal-title":"JAMA Ophthalmol"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc Natl Acad Sci USA."},{"key":"bib4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1101\/gad.12.2.149","article-title":"Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha","volume":"12","author":"Iyer","year":"1998","journal-title":"Genes Dev"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nri3790","article-title":"Clinical blockade of PD1 and LAG3\u2014potential mechanisms of action","volume":"15","author":"Nguyen","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"bib7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/cam4.106","article-title":"PD-1 as a potential target in cancer therapy","volume":"2","author":"McDermott","year":"2013","journal-title":"Cancer Med"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/08820130902912332","article-title":"Soluble PD-1 is associated with aberrant regulation of T cells activation in aplastic anemia","volume":"38","author":"Wu","year":"2009","journal-title":"Immunol Invest"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"e1390","DOI":"10.1038\/cddis.2014.351","article-title":"Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2","volume":"5","author":"Bertsch","year":"2014","journal-title":"Cell Death Dis"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semcdb.2015.01.012","article-title":"Fas and TRAIL \u2018death receptors\u2019 as initiators of inflammation: Implications for cancer","volume":"39","author":"Cullen","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/cdd.2013.28","article-title":"Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family","volume":"20","author":"Azijli","year":"2013","journal-title":"Cell Death Differ"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"5649214","DOI":"10.1155\/2017\/5649214","article-title":"Dengue virus induces NK cell activation through TRAIL expression during infection","volume":"2017","author":"Gandini","year":"2017","journal-title":"Mediators Inflamm"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1038\/s41598-018-23848-8","article-title":"Circulating levels of inflammatory proteins and survival in patients with gallbladder cancer","volume":"8","author":"Liu","year":"2018","journal-title":"Sci Rep"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"e1309","DOI":"10.1038\/cddis.2014.260","article-title":"Activation of HIF-1alpha (hypoxia inducible factor-1alpha) prevents dry eye-induced acinar cell death in the lacrimal gland","volume":"5","author":"Seo","year":"2014","journal-title":"Cell Death Dis"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1006\/exer.1996.0064","article-title":"Organ culture of human main and accessory lacrimal glands and their secretory behaviour","volume":"62","author":"Hunt","year":"1996","journal-title":"Exp Eye Res"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1182\/blood-2010-09-306928","article-title":"Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7-dependent pathway","volume":"117","author":"Lee","year":"2011","journal-title":"Blood"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/ATVBAHA.114.305228","article-title":"PTK7+ mononuclear cells express VEGFR2 and contribute to vascular stabilization by upregulating angiopoietin-1","volume":"35","author":"Chauhan","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.1167\/iovs.14-14744","article-title":"Dry eye-induced CCR7+CD11b+ cell lymph node homing is induced by COX-2 activities","volume":"55","author":"Ji","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"7557","DOI":"10.1167\/iovs.12-11515","article-title":"Neutralization of ocular surface TNF-alpha reduces ocular surface and lacrimal gland inflammation induced by in vivo dry eye","volume":"54","author":"Ji","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1172\/JCI200421086","article-title":"Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis","volume":"114","author":"Karhausen","year":"2004","journal-title":"J Clin Invest"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nrc2501","article-title":"Hypoxia signalling through mTOR and the unfolded protein response in cancer","volume":"8","author":"Wouters","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.4049\/jimmunol.182.3.1247","article-title":"Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression","volume":"182","author":"Chauhan","year":"2009","journal-title":"J Immunol"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/mi.2009.5","article-title":"IL-17 disrupts corneal barrier following desiccating stress","volume":"2","author":"De Paiva","year":"2009","journal-title":"Mucosal Immunol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1158\/0008-5472.CAN-13-0992","article-title":"A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells","volume":"74","author":"Barsoum","year":"2014","journal-title":"Cancer Res"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"e1004252","DOI":"10.1371\/journal.ppat.1004252","article-title":"Disruption of fas-fas ligand signaling, apoptosis, and innate immunity by bacterial pathogens","volume":"10","author":"Caulfield","year":"2014","journal-title":"PLoS Pathog"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"4739","DOI":"10.4049\/jimmunol.169.9.4739","article-title":"TRAIL: a mechanism of tumor surveillance in an immune privileged site","volume":"169","author":"Lee","year":"2002","journal-title":"J Immunol"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.4049\/jimmunol.1401572","article-title":"The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity","volume":"193","author":"Ostrand-Rosenberg","year":"2014","journal-title":"J Immunol"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1096\/fj.10-170480","article-title":"The role of TRADD in TRAIL-induced apoptosis and signaling","volume":"25","author":"Cao","year":"2011","journal-title":"FASEB J"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1046\/j.0022-202x.2001.01477.x","article-title":"Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand","volume":"117","author":"Qin","year":"2001","journal-title":"J Invest Dermatol"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/art.33492","article-title":"Epirubicin potentiates recombinant adeno-associated virus type 2\/5-mediated TRAIL expression in fibroblast-like synoviocytes and augments the antiarthritic effects of rAAV2\/5-TRAIL","volume":"64","author":"Shi","year":"2012","journal-title":"Arthritis Rheum"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1007\/s10495-008-0261-2","article-title":"Rapid and significant induction of TRAIL-mediated type II cells in apoptosis of primary salivary epithelial cells in primary Sj\u00f6gren's syndrome","volume":"13","author":"Nakamura","year":"2008","journal-title":"Apoptosis"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cytogfr.2013.12.009","article-title":"Death receptor agonist therapies for cancer, which is the right TRAIL?","volume":"25","author":"Holland","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1038\/s41598-017-13817-y","article-title":"Proteomic analysis of human lacrimal and tear fluid in dry eye disease","volume":"7","author":"Jung","year":"2017","journal-title":"Sci Rep"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1136\/jcp.2003.015032","article-title":"The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis","volume":"57","author":"Greijer","year":"2004","journal-title":"J Clin Pathol"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1084\/jem.20040624","article-title":"Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity","volume":"201","author":"Walmsley","year":"2005","journal-title":"J Exp Med"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"8628","DOI":"10.1038\/sj.onc.1207232","article-title":"TRAIL and apoptosis induction by TNF-family death receptors","volume":"22","author":"Wang","year":"2003","journal-title":"Oncogene"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.biopha.2017.12.082","article-title":"TNF-related apoptosis-inducing ligand (TRAIL) as the potential therapeutic target in hematological malignancies","volume":"98","author":"Naimi","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"7046","DOI":"10.1128\/MCB.00520-06","article-title":"Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2","volume":"26","author":"Merino","year":"2006","journal-title":"Mol Cell Biol"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"18099","DOI":"10.1073\/pnas.0507329102","article-title":"Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis","volume":"102","author":"Clancy","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib41","first-page":"612","article-title":"TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL","volume":"90","author":"Riccioni","year":"2005","journal-title":"Haematologica"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/imm.2009.127.issue-2","article-title":"Following TRAIL\u2019s path in the immune system","volume":"127","author":"Falschlehner","year":"2009","journal-title":"Immunology"},{"key":"bib43","first-page":"791","article-title":"Expression of TNF-related apoptosis inducing ligand (TRAIL) on infiltrating cells and of TRAIL receptors on salivary glands in patients with Sj\u00f6gren's syndrome","volume":"20","author":"Matsumura","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.immuni.2014.09.013","article-title":"TRAIL+ NK cells control CD4+ T cell responses during chronic viral infection to limit autoimmunity","volume":"41","author":"Schuster","year":"2014","journal-title":"Immunity"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fphar.2016.00184","article-title":"Hypoxia-inducible factor (HIF) as a target for novel therapies in rheumatoid arthritis","volume":"7","author":"Hua","year":"2016","journal-title":"Front Pharmacol"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2760086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:17Z","timestamp":1791927077000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2760086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,23]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.61.1.3","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,29]]}}}